<DOC>
	<DOC>NCT01763307</DOC>
	<brief_summary>Vitamin K1 cream may prevent papulopustular rash induced by EGFRI given to metastatic colorectal cancer patients. This study will prospectively accrue metastatic colorectal patients receiving EGFRI and treat with reconval cream half face versus placebo cream half face to study whether Vitamin k1 cream can prevent the typical skin eruption caused by EGFRI.</brief_summary>
	<brief_title>A Study to Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI</brief_title>
	<detailed_description />
	<criteria>metastatic colon cancer patients male or female age&gt; 18 treated EGFRI prior treatment with EGFRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>EGFRI</keyword>
	<keyword>COLON CANCER</keyword>
	<keyword>SKIN TOXICITY</keyword>
	<keyword>RECONVAL K1 cream</keyword>
</DOC>